BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22941525)

  • 21. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival.
    Degos L
    Leukemia; 1994 Jun; 8(6):911-3. PubMed ID: 8207982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute promyelocytic leukemia in children and adolescents.
    Stein EM; Tallman MS
    Acta Haematol; 2014; 132(3-4):307-12. PubMed ID: 25228556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):98-105. PubMed ID: 11066455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curative therapeutic approaches to APL.
    Tallmann MS
    Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid therapy of childhood cancer.
    Reynolds CP; Lemons RS
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
    Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoids and differentiation treatment: a strategy for treatment in cancer.
    Cornic M; Agadir A; Degos L; Chomienne C
    Anticancer Res; 1994; 14(6A):2339-46. PubMed ID: 7825969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.
    Muchtar E; Vidal L; Ram R; Gafter-Gvili A; Shpilberg O; Raanani P
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009594. PubMed ID: 23543579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC
    Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia.
    Bapna A; Nair R; Tapan KS; Nair CN; Kadam P; Gladstone B; Advani SH
    Pediatr Hematol Oncol; 1998; 15(3):243-8. PubMed ID: 9615322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unlocking the potential of retinoic acid in anticancer therapy.
    Schenk T; Stengel S; Zelent A
    Br J Cancer; 2014 Nov; 111(11):2039-45. PubMed ID: 25412233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute promyelocytic leukaemia].
    Reikvam H; Hovland R; Bruserud Ø
    Tidsskr Nor Laegeforen; 2014 May; 134(10):1052-5. PubMed ID: 24865730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh.
    Khan ER; Islam A; Jamal CY; Karim MA; Rahman AA; Hafiz MG; Khaleque A
    Pediatr Hematol Oncol; 2022 Aug; 39(5):406-417. PubMed ID: 34986070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC
    Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.